Tendon Dysfunction in Collagen VI-Related Myopathies: Novel Mechanistic Insights with Therapeutic Potential
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262412014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Patrizia Sabatelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: CNR-Institute of Molecular Genetics, 40136 Bologna, Italy. Hauptthemen laut MEDLINE: Collagen Type VI, Tendons, Muscular Diseases. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cure-CMD / AFM telethon, Italian Ministry of University and Research, Cure-CMD.
Abstract (Originalsprache)
Collagen VI-related myopathies (COL6-RM) encompass a spectrum of disorders characterized by muscle weakness, joint contractures, and connective tissue abnormalities resulting from mutations in the collagen VI genes. While muscle pathology has been extensively studied, tendon dysfunction has emerged as a critical yet underexplored contributor to disease severity, particularly in the development of joint contractures. Tendons from patients and animal models show disrupted collagen fibrillogenesis, altered extracellular matrix (ECM) composition, and impaired cellular mechanotransduction. Various defects in ECM remodeling pathways further exacerbate tendon pathology. Importantly, current clinical management remains limited to orthopedic interventions with modest outcomes, and targeted pharmacological strategies or gene-editing therapies are not yet available for clinical application. Therefore, understanding the basic pathogenic mechanisms underlying tendon dysfunction is essential for identifying novel therapeutic targets. This review provides a comprehensive synthesis of current understanding and recent advances concerning the role of mutated collagen VI in cellular and molecular mechanisms underlying tendon dysfunction. Emphasis is placed on the role of mutated collagen VI in the modulation of key signaling pathways related to mechanotransduction and primary cilium function in COL6-RM. By discussing these multifaceted contributions to disease pathogenesis, this review outlines future research directions in the field and highlights potential pathways for targeted therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNR-Institute of Molecular Genetics, 40136 Bologna, Italy.
- IRCCS, Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
- 1st Orthopedics and Traumatology Department, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
- Department of Biomedical and Neuromotor Science, DIBINEM, University of Bologna, 40136 Bologna, Italy.
- Department of Molecular Medicine, University of Padova, 35122 Padova, Italy.
ORCID-Profile: Alberto Di Martino, Cesare Faldini, Paolo Bonaldo, Luciano Merlini, Vittoria Cenni
Förderung
- Cure-CMD / AFM telethon
- Italian Ministry of University and Research
- Cure-CMD
Zitieren
APA
Sabatelli, P., Di Martino, A., Faldini, C., Bonaldo, P., Merlini, L., & Cenni, V. (2025). Tendon Dysfunction in Collagen VI-Related Myopathies: Novel Mechanistic Insights with Therapeutic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412014
Vancouver
Sabatelli P, Di Martino A, Faldini C, Bonaldo P, Merlini L, Cenni V. Tendon Dysfunction in Collagen VI-Related Myopathies: Novel Mechanistic Insights with Therapeutic Potential. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412014
BibTeX
@article{Sabatelli2025,
author = {Sabatelli, Patrizia and Di Martino, Alberto and Faldini, Cesare and Bonaldo, Paolo and Merlini, Luciano and Cenni, Vittoria},
title = {Tendon Dysfunction in Collagen VI-Related Myopathies: Novel Mechanistic Insights with Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262412014}
}
EUVIMED